925. Infectious Complications Following Chimeric Antigen Receptor (CAR) T-cell Therapy

BACKGROUND: Chimeric antigen receptor (CAR-T) T-cell therapy is a novel immunotherapy for cancer treatment in which patients are treated with targeted, genetically-modified T-cells. Common side effects include cytokine release syndrome, neurotoxicity, hypogammaglobulinemia, and increased susceptibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Trottier, Caitlin, Larsen, Christian, Bindal, Poorva, Dodge, Laura E, Elavalakanar, Pavania, Knudsen, Elisabeth, Kim, Sirwoo, Logan, Emma, Urman, Arielle R, Frigault, Matthew, Fishman, Jay A, Arnason, Jon, Alonso, Carolyn D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644649/
http://dx.doi.org/10.1093/ofid/ofab466.1120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644649/
http://dx.doi.org/10.1093/ofid/ofab466.1120

Ejemplares similares